N. Semmo

Discipline

Economies et finances (1)

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Treatment (5) Hepatitis C virus (5) Liver (5) infection (4) Infection (4) association (3) Social groups (3) Patients (3) Antiviral agents (3) Utilization (3) Patients (3) temps (durée) (2) risque (2) protéine (2) mortalité (2) surveillance (2) gène (2) Monitoring (2) Mortality (2) Development (2) Identification (2) Genes (2) Rates (2) Time (2) Swiss (2) Risk (2) Proportion (2) Persons (2) Mortality (2) Human beings (2)

Documents écrit par N. Semmo (6) | parle de N. Semmo (0)

Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
O. Manuel et al. (17 févr. 2024)
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS).
M. Roelens et al.
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study.
M. Brezzi et al. (2019)
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing.
F. About et al. (2019)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
S. Bibert et al. (2014)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.
S. Bibert et al. (2013)